399 related articles for article (PubMed ID: 33028168)
1. The emerging role of targeting cancer metabolism for cancer therapy.
Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
[TBL] [Abstract][Full Text] [Related]
2. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
[TBL] [Abstract][Full Text] [Related]
3. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
5. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy.
Wang QQ; Li MX; Li C; Gu XX; Zheng MZ; Chen LX; Li H
Curr Med Sci; 2020 Apr; 40(2):205-217. PubMed ID: 32337682
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic targets of tumor metabolism.
Kishton RJ; Rathmell JC
Cancer J; 2015; 21(2):62-9. PubMed ID: 25815845
[TBL] [Abstract][Full Text] [Related]
7. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
Pusapati RV; Daemen A; Wilson C; Sandoval W; Gao M; Haley B; Baudy AR; Hatzivassiliou G; Evangelista M; Settleman J
Cancer Cell; 2016 Apr; 29(4):548-562. PubMed ID: 27052953
[TBL] [Abstract][Full Text] [Related]
8. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
Gomes AS; Ramos H; Soares J; Saraiva L
Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
[TBL] [Abstract][Full Text] [Related]
9. Back to the Future: Therapeutic Targeting of Cancer Cell Metabolism.
Gilmour R; Velasco S
SLAS Discov; 2017 Apr; 22(4):333-337. PubMed ID: 28328320
[No Abstract] [Full Text] [Related]
10. Mitochondria Targeting as an Effective Strategy for Cancer Therapy.
Ghosh P; Vidal C; Dey S; Zhang L
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397535
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
[TBL] [Abstract][Full Text] [Related]
12. Clinical development of cancer therapeutics that target metabolism.
Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
[TBL] [Abstract][Full Text] [Related]
13. Targeting Energy Metabolism in Cancer Treatment.
Kubik J; Humeniuk E; Adamczuk G; Madej-Czerwonka B; Korga-Plewko A
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628385
[TBL] [Abstract][Full Text] [Related]
14. Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.
Kim ES; Isoda F; Kurland I; Mobbs CV
Endocrinology; 2013 Sep; 154(9):3054-66. PubMed ID: 23709088
[TBL] [Abstract][Full Text] [Related]
15. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
Levine AJ; Puzio-Kuter AM
Science; 2010 Dec; 330(6009):1340-4. PubMed ID: 21127244
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell metabolism: a potential target for cancer therapy.
Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
[TBL] [Abstract][Full Text] [Related]
17. Targeting of cancer energy metabolism.
Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Carreño-Fuentes L; Moreno-Sánchez R
Mol Nutr Food Res; 2009 Jan; 53(1):29-48. PubMed ID: 19123180
[TBL] [Abstract][Full Text] [Related]
18. Glycolysis-induced drug resistance in tumors-A response to danger signals?
Marcucci F; Rumio C
Neoplasia; 2021 Feb; 23(2):234-245. PubMed ID: 33418276
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Phosphorylation as an Emerging Target in Cancer Therapy.
Ashton TM; McKenna WG; Kunz-Schughart LA; Higgins GS
Clin Cancer Res; 2018 Jun; 24(11):2482-2490. PubMed ID: 29420223
[TBL] [Abstract][Full Text] [Related]
20. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
